Dunkler Urin: Kenne die Hauptursachen und was zu tun ist
Thank you for visiting nature. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser or turn off compatibility mode in Internet Explorer.
In this article, we review the current literature and present a structured summary in management of AUR. The obtained literature was manually reviewed by the primary author PDY and was further refined by confining the subject to management of AUR. Exclusion criteria included paediatric and female population studies, case reports, reviews, surveys, economical assessment and articles on AUR in prostate cancer and post-operative patients.
Total of 54 articles met our inclusion and exclusion criteria. The trial without catheter TWOC post-immediate catheterisation is widely practiced although there remains a significant variability in terms of type and duration of catheterisation required, use of concurrent medical therapy or post-catheterisation BPH brauner Urin.
Suprapubic catheter SPC is an alternative to BPH brauner Urin catheterisation indwelling catheter IDC and may provide several advantages. Clean intermittent self-catheterisation may be a safe and useful option for patients with AUR until their definitive management. The overall long-term outcome of in-and-out catheterisation remains promising in selected patients. Although TURP remains the current gold standard, there has been an emergence of newer operative management utilising laser techniques.
Kalejaiye O, Speakman MJ. Management of acute and chronic retention in men. Eur Urol Suppl ; 8 : — Natural history of prostatism: risk factors for BPH brauner Urin urinary retention.
J Urol ; : — The management of acute urinary retention in France: a cross-sectional survey in men with benign prostatic hyperplasia. BJU Int ; 97 : — Acute urinary retention: what is the impact on patients' quality of life? BJU Int ; 95 : 72— The incidence of acute urinary retention secondary to BPH is increasing among California men. Prostate Cancer Prostatic Dis ; 16 : — Incidence of primary and recurrent acute urinary retention between and in England.
J Urol ; : —; discussion 4. Mortality in men admitted to hospital with acute urinary retention: database analysis. Br Med J ; : — Management of acute urinary retention: a worldwide survey of men with benign prostatic hyperplasia. BJU Int ; : 88— Emberton M, Fitzpatrick JM. The Reten-World survey of the management of acute urinary retention: preliminary results. BJU Int ; : 27— Management of acute urinary retention. BJU Int ; 97 : 16— Analysis of the treatment of two types of acute urinary retention.
Korean J Urol ; 53 : — The management of acute urinary retention: treating the curse of the aging male. Curr Bladder Dysfunct Rep ; 8 : — Acute urinary retention: a review of the aetiology and management. Prostate Cancer Prostatic Dis ; 7 : 32— Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey. BJU Int ; 93 : BPH brauner Urin Questionnaire survey of urologists' initial treatment practices for acute urinary retention secondary to benign prostatic hyperplasia in Korea.
BPH brauner Urin Int ; 76 : — Does prolonged catheter drainage improve the chance of recovering voluntary voiding after acute urinary retention AUR. Eur Urol ; 33 : Taube M, Gajraj H. Trial without catheter following acute retention of urine. Br J Urol ; 63 : — Ambulatory care program for patients presenting with acute urinary retention BPH brauner Urin to benign prostatic hyperplasia.
Int Urol Nephrol ; BPH brauner Urin : — Acute urinary retention. Comparison of suprapubic and urethral catheterisation. Br J Urol ; 70 : — The surgical risk of suprapubic catheter insertion and long-term sequelae. Ann R Coll Surg Engl ; 88 : — British Association of Urological Surgeons' suprapubic catheter practice BPH brauner Urin. BJU Int ; : 77— The optimal form of urinary drainage after acute retention of urine.
BJU Int ; 88 : 26— The efficacy of in-and-out catheterization as a way of trial without catheterization strategy for treatment of acute urinary retention induced by benign prostate hyperplasia: variables predicting success outcome.
Neurourol Urodyn ; 31 : — Clean intermittent catheterization and urinary tract infection: review and guide for future research. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol ; 47 : — Zeif HJ, Subramonian K. Alpha blockers prior to removal of a catheter for acute urinary retention in adult men. Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention.
Urology ; 82 : — Alfuzosin 10 mg once daily BPH brauner Urin the management of acute urinary retention: results of a double-blind BPH brauner Urin study. Urology ; 65 : 83—89 discussion Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. BJU Int ; 95 : — Alfuzosin 10 mg once daily increases the chances BPH brauner Urin successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia. Urol Int ; 83 : 44— Randomised, placebo controlled, BPH brauner Urin blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention.
Eur Urol ; 42 : —; discussion BPH brauner Urin Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled. BJU Int ; BPH brauner Urin : — A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal BPH brauner Urin patients with benign prostatic growth. Int Urol Nephrol ; 46 : — A prospective randomized study comparing alfuzosin and tamsulosin in the BPH brauner Urin of patients BPH brauner Urin from acute urinary retention caused by benign prostatic hyperplasia.
Indian J Urol ; 25 : — Natl J Androl ; 9 : — Al-Hashimi MMR. Alfuzosin 10 mg once daily in the management of acute BPH brauner Urin retention of benign prostatic hyperplasia: a double-blind, placebo-controlled study. Curr Urol ; 1 : 28— Efficacy of doxazosin in the treatment of acute urinary retention BPH brauner Urin to benign prostate hyperplasia.
Urol Int ; 81 : 66— Dose increase action on recovery effect]. Actas Urol Esp ; 28 : 32— Urologiia ; 3 : 18— PMID: Marberger MJ. Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study.